DCTH Announces Publication of CHOPIN Trial in The Lancet Oncology Shows 54.7% 1-Year PFS, 49.6% 2-Year OS, 76.3% ORR, 23.1-Month Median OS, 34% Grade 3 Thrombocytopenia
Delcath Systems Inc · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $10.60
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS